Agilent Technologies (A)

The sleeper story is that Agilent has become a pricing power story masquerading as a cyclical recovery play: 200bps from price, tariffs fully mitigated, and Ignite driving structural margin expansion that Wall Street is underappreciating. The headline beat and raise looks like typical cycle momentum, but the binding constraint has shifted from demand to supply chain velocity and capacity, evidenced by nine quarters of book-to-bill above parity. China's sharp Q2 deterioration from +6% to -9% is being papered over with 'prudent outlook' language while management quietly stopped disclosing order visibility metrics. Most revealing quote: 'degree of prudence embedded in our H2 outlook' which is code for China visibility has evaporated. My view changes if China stimulus materializes in Q4 or if pricing power evaporates when volumes return.